These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17698414)

  • 1. Photoinactivation of Trypanosoma cruzi in red cell suspensions with thiopyrylium.
    Wagner SJ; Skripchenko A; Salata J; Cardo LJ
    Transfus Apher Sci; 2007 Aug; 37(1):23-5. PubMed ID: 17698414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoinactivation of Leishmania donovani infantum in red cell suspensions by a flexible thiopyrylium sensitizer.
    Wagner SJ; Skripchenko A; Salata J; Cardo LJ
    Vox Sang; 2006 Aug; 91(2):178-80. PubMed ID: 16907880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood donor screening for chagas disease--United States, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):141-3. PubMed ID: 17318113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for prevention of transfusion-associated Chagas' disease.
    Moraes-Souza H; Bordin JO
    Transfus Med Rev; 1996 Jul; 10(3):161-70. PubMed ID: 8809967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem.
    Kitchen AD; Hewitt PE; Chiodini PL
    Transfusion; 2012 Sep; 52(9):1931-9. PubMed ID: 22414025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-sialidase inhibition assay for the detection of Trypanosoma cruzi infection in blood donor samples from Argentina.
    Blejer JL; Sartor PA; Bottasso O; Salamone HJ; Leguizamón MS
    Vox Sang; 2008 Oct; 95(3):189-96. PubMed ID: 19121183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chagas disease and transfusion medicine: a perspective from non-endemic countries.
    Angheben A; Boix L; Buonfrate D; Gobbi F; Bisoffi Z; Pupella S; Gandini G; Aprili G
    Blood Transfus; 2015 Oct; 13(4):540-50. PubMed ID: 26513769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enfermedad de Chagas en México].
    Rojo-Medina J; Ruiz-Matus C; Salazar-Schettino PM; González-Roldán JF
    Gac Med Mex; 2018; 154(5):605-612. PubMed ID: 30407465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control measures for Chagas disease.
    Cruz-Pacheco G; Esteva L; Vargas C
    Math Biosci; 2012 May; 237(1-2):49-60. PubMed ID: 22450034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission.
    Leiby DA; Herron RM; Read EJ; Lenes BA; Stumpf RJ
    Transfusion; 2002 May; 42(5):549-55. PubMed ID: 12084162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
    Assal A; Corbi C
    Transfus Clin Biol; 2011 Apr; 18(2):286-91. PubMed ID: 21440479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi.
    Appleman MD; Shulman IA; Saxena S; Kirchhoff LV
    Transfusion; 1993 Jan; 33(1):61-4. PubMed ID: 8424268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of Chagas disease among at-risk blood donors in Italy: preliminary results from Umberto I Polyclinic in Rome.
    Gabrielli S; Girelli G; Vaia F; Santonicola M; Fakeri A; Cancrini G
    Blood Transfus; 2013 Oct; 11(4):558-62. PubMed ID: 24120609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi.
    Custer B; Agapova M; Bruhn R; Cusick R; Kamel H; Tomasulo P; Biswas H; Tobler L; Lee TH; Caglioti S; Busch M
    Transfusion; 2012 Sep; 52(9):1901-11. PubMed ID: 22339233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Trypanosoma cruzi infection in California blood donors.
    Galel SA; Kirchhoff LV
    Transfusion; 1996 Mar; 36(3):227-31. PubMed ID: 8604507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Trypanosoma cruzi in Eight Blood Banks in Mexico.
    González-Guzmán S; González-Cano P; Bagu ET; Vázquez-Vega S; Martínez-Salazar M; Juárez-Montiel M; Gutiérrez-Hoya A; Crescencio-Trujillo JA; Sánchez-Montes S; Fernández-Figueroa E; Contreras-López EA; Guerra-Márquez Á; Arroyo-Anduiza CI; Ángeles-Márquez LE; Rodríguez-Trejo E; Bekker-Méndez C; Guerra-Castillo FX; Regalado-Santiago C; Tesoro-Cruz E; Oviedo N; Victoria-Jardón AM; Bautista-Olvera J; García-Ramírez P; Vázquez-Meraz JE; Contreras-Lozano MC; Castillo-Flores VS; Guevara-Reyes R; Girón-Sánchez AR; Arenas-Luis HD; Pecero-Hidalgo MJ; Ríos-Antonio E; Ramírez-Pereda N; Martínez-Mora A; Paredes-Cervantes V
    Arch Med Res; 2022 Sep; 53(6):625-633. PubMed ID: 36109203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ donor screening practices for Trypanosoma cruzi infection among US Organ Procurement Organizations.
    Schwartz BS; Paster M; Ison MG; Chin-Hong PV
    Am J Transplant; 2011 Apr; 11(4):848-51. PubMed ID: 21426487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission.
    Leiby DA; Fucci MH; Stumpf RJ
    Transfusion; 1999 Mar; 39(3):310-5. PubMed ID: 10204596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center.
    Kessler DA; Shi PA; Avecilla ST; Shaz BH
    Transfusion; 2013 May; 53(5):1083-7. PubMed ID: 22897737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.